Ledgerwood 2015.
Trial name or title | Sequential Multiple Assignment Randomized Trial (SMART) |
Methods | Two‐phase randomized controlled trial |
Participants | Current adult smokers enrolled in an HIV clinic with a diagnosis of HIV/AIDS |
Interventions | Phase 1: participants are randomized to receive either standard care (brief counselling and bupropion) or standard care and entry into a prize draw (contingency management) Phase 2a: non‐responders from Phase 1 are randomized to receive continued counselling and monitoring support, with or without a prize draw Phase 2b: responders from Phase 1 are randomized to receive either no additional treatment, or continued monitoring + a prize draw |
Outcomes | Primary outcomes: urinary cotinine, longest duration of continuous abstinence, 7‐day self‐reported point prevalence, carbon monoxide at follow‐up times up to 12 months |
Starting date | August 2013 |
Contact information | Lisa Sulkowski, Wayne State University (lsulkows@med.wayne.edu) David Ledgerwood, Wayne State University |
Notes |